SCHEMBL1421834

SCHEMBL1421834

COc1nc(N)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.62
ALDH1A1 P00352 7/20 0.62
MAPT P10636 6/20 0.62
NPSR1 Q6W5P4 6/20 0.62
RXFP1 Q9HBX9 5/20 0.62
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
HSD17B10 Q99714 4/20 0.62
HPGD P15428 3/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
CASP1 P29466 1/20 0.62
CASP7 P55210 1/20 0.62
ADORA1 P30542 9/20 0.58
ADORA2A P29274 1/20 0.54
USP2 O75604 1/20 0.53
TP53 P04637 1/20 0.53
ALOX15 P16050 1/20 0.53
PRF1 P14222 1/20 0.51
SLC6A3 Q01959 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421425 0.89 ADORA1 (0.56) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL1422139 0.88 ADORA1 (0.47) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL12536078 0.87 ADORA1 (0.53) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL1421727 0.85 PRF1 (0.51) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL12553020 0.84 ADORA1 (0.56) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL6462280 0.84 ADORA1 (0.63) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL30511861 0.82 PRF1 (0.58) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL245940 0.82 PRF1 (0.58) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL1421689 0.82 KDM4E (0.67) KDM4EALDH1A1MAPTNPSR1RXFP1
SCHEMBL6461004 0.82 KDM4E (0.70) KDM4EALDH1A1MAPTNPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9205077-B2 2-alkoxy-substituted dicyanopyridines and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-08 US disclosed
US-9205077-B2 2-alkoxy-substituted dicyanopyridines and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-08 US disclosed
US-20140296295-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-02 US disclosed
US-20140296295-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-02 US disclosed
US-8791146-B2 2-alkoxy-substituted dicyanopyridines and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-07-29 US disclosed
US-8791146-B2 2-alkoxy-substituted dicyanopyridines and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-07-29 US disclosed
EP-2297104-B1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER IP GMBH (DE) 2013-08-07 EP disclosed
EP-2297104-B1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER IP GMBH (DE) 2013-08-07 EP disclosed
US-20110136871-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE BAYER SCHERING AKTIENGESELLSCHAFT (DE) 2011-06-09 US disclosed
US-20110136871-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE BAYER SCHERING AKTIENGESELLSCHAFT (DE) 2011-06-09 US disclosed
EP-2297104-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-03-23 EP disclosed
WO-2009143992-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-12-03 WO disclosed
WO-2009143992-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136871-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE QDPR, TNNI3, TNNT2 KDM4E 2290/4885ALDH1A1 747/4885MAPT 3819/4885
US-20140296295-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND THEIR USE QDPR, TNNI3, TNNT2 KDM4E 2290/4885ALDH1A1 747/4885MAPT 3819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.